WHAT IS THE REAL IMPACT OF DEPRESSION ON CLINICAL RESPONSE TO THERAPY IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS?

被引：0
作者：
Martins, A. [1 ,2 ]
Oliveira, D. Santos [1 ,2 ,3 ]
Nicolau, R. [2 ,4 ]
Martins-Rocha, T. [1 ,2 ]
Bernardo, A. [1 ]
Pimenta, S. [1 ,2 ]
Bernardes, M. [1 ,2 ]
Costa, L. [1 ]
机构：
[1] Sao Joao Univ Hosp Ctr, Rheumatol, Porto, Portugal
[2] Univ Porto FMUP, Fac Med, Med, Porto, Portugal
[3] Univ Porto FMUP, Fac Med, CINTESIS, Porto, Portugal
[4] Ctr Hosp Tondela Viseu, Epe, Rheumatol, Viseu, Portugal
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Psoriatic arthritis; bDMARD;
D O I：
10.1136/annrheumdis-2023-eular.1101
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1129 / 1129
页数：1
相关论文
共 50 条
[31]   Comparison of effectiveness and safety of infliximab, etanercept, and adalimumab in psoriatic arthritis patients who experienced an inadequate response to previous disease-modifying antirheumatic drugs [J].
Atteno, Mariangela ;
Peluso, Rosario ;
Costa, Luisa ;
Padula, Stefania ;
Iervolino, Salvatore ;
Caso, Francesco ;
Sanduzzi, Alessandro ;
Lubrano, Ennio ;
Del Puente, Antonio ;
Scarpa, Raffaele .
CLINICAL RHEUMATOLOGY, 2010, 29 (04) :399-403
[32]   The 2023 pipeline of disease-modifying antirheumatic drugs (DMARDs) in clinical development for spondyloarthritis (including psoriatic arthritis): a systematic review of trials [J].
Denis, Agathe ;
Sztejkowski, Cedric ;
Arnaud, Laurent ;
Becker, Guillaume ;
Felten, Renaud .
RMD OPEN, 2023, 9 (03)
[33]   Life-table analysis of cyclosporin A treatment in psoriatic arthritis: Comparison with other disease-modifying antirheumatic drugs [J].
Spadaro, A ;
Taccari, E ;
Mohtadi, B ;
Riccieri, V ;
Sensi, F ;
Zoppini, A .
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1997, 15 (06) :609-614
[34]   Clinical characteristics, disease activity, functional status, and quality of life results of patients with psoriatic arthritis using biological and conventional synthetic disease-modifying antirheumatic drugs [J].
Keskin, Yasar ;
Nas, Kemal ;
Kilic, Erkan ;
Sargin, Betul ;
Kasman, Sevtap Acer ;
Alkan, Hakan ;
Sahin, Nilay ;
Cengiz, Gizem ;
Cuzdan, Nihan ;
Gezer, Ilknur Albayrak ;
Keskin, Dilekk ;
Mulkoglu, Cevriye ;
Resorlu, Hatice ;
Ataman, Sebnem ;
Bal, Ajda ;
Duruoz, Mehmet Tuncay ;
Kucukakkas, Okan ;
Yurdakul, Ozan Volkan ;
Melikoglu, Meltem Alkan ;
Aydin, Yildiray ;
Ayhan, F. Figen ;
Bodur, Hatice ;
Calis, Mustafa ;
Capkin, Erhan ;
Devrimsel, Gul ;
Gok, Kevser ;
Hizmetli, Sami ;
Kamanli, Ayhan ;
Ecesoy, Hilal ;
Kutluk, Oznur ;
Sen, Nesrin ;
Sendur, Omer Faruk ;
Tekeoglu, Ibrahim ;
Tolu, Sena ;
Toprak, Murat ;
Tuncer, Tiraje .
ARCHIVES OF RHEUMATOLOGY, 2021, 36 (01) :1-9
[35]   Prevalence of minimal disease activity in Australian patients with Psoriatic Arthritis: Assessing the outcome of national funding criteria for biologic disease-modifying antirheumatic drug prescribing [J].
Pontifex, Eliza K. ;
Dissanayake, Kokum ;
Bursill, David ;
Gill, Tiffany .
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2019, 22 (02) :262-268
[36]   VACCINATION UPTAKE IN A COHORT OF PATIENTS ON BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (BDMARDS) AT A MELBOURNE PUBLIC HOSPITAL [J].
Pourhadi, H. ;
Johnson, A. ;
Foote, A. .
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 :2139-2139
[37]   Patients' Attitudes and Experiences of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis and Spondyloarthritis: A Qualitative Synthesis [J].
Kelly, Ayano ;
Tymms, Kathleen ;
Tunnicliffe, David J. ;
Sumpton, Daniel ;
Perera, Chandima ;
Fallon, Kieran ;
Craig, Jonathan C. ;
Abhayaratna, Walter ;
Tong, Allison .
ARTHRITIS CARE & RESEARCH, 2018, 70 (04) :525-532
[38]   High rates of therapeutic changes in patients with psoriatic arthritis receiving treatment with disease-modifying antirheumatic drugs: A cross-sectional study [J].
Behrens, Frank ;
Rech, Jurgen ;
Thaci, Diamant ;
Zinke, Silke ;
Rothnie, Kieran J. ;
Daamen, Carolin ;
Leipe, Jan .
MODERN RHEUMATOLOGY, 2022, 32 (01) :87-95
[39]   South African Rheumatism and Arthritis Association 2024 guidelines for the use of biologic and targeted synthetic disease-modifying antirheumatic drugs [J].
van Duuren, E. ;
Potts, J. ;
Brijlal, U. ;
Botha, S. ;
Didi, S. ;
Makan, K. ;
van Dam, M. ;
Chinniah, K. ;
Hodkinson, B. .
SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2024, 114 (09) :24-36
[40]   Factors predicting treatment response to biological and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis - a systematic review and meta-analysis [J].
Kunzler, Tabea ;
Bamert, Manuel ;
Sprott, Haiko .
CLINICAL RHEUMATOLOGY, 2024, 43 (12) :3723-3746
12345